Update date
30 Jun 2025
Shareable Research Card
ATHE - ALTERITY THERAPEUTICS LTD Interest Expense
This metric view shows ATHE - ALTERITY THERAPEUTICS LTD interest expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2025
- Latest reported value
- A$6,188
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 30 Jun 2025
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2025.
- Latest reported value on this page: A$6,188.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Interest Expense
Latest reported interest expense: A$6,188. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2025
SEC-backed company facts were refreshed from filings filed on 29 Aug 2025.
Benchmark Context
How Interest Expense compares with peers
ALTERITY THERAPEUTICS LTD sits in the bottom quarter of the current interest expense sample.
Compared with
Compared with 13 companies reporting interest expense in AUD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0.3x the current sample midpoint. Interest Expense is down about 14% versus the comparable prior period.
- Visible rows currently span reported period ends from 30 Jun 2016 to 30 Jun 2025.
- Nearby companies in this sample: ioneer Ltd and Integrated Media Technology Ltd.
- Current sample position: rank #11 of 13 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
ALTERITY THERAPEUTICS LTD: Interest Expense
Latest period: 2025. Period end: 30 Jun 2025. Units: AUD. Frequency: annual.
Interest Expense is reported in company XBRL facts filed with the SEC.
Metric Snapshot
- Latest value
- A$6,188
- Coverage range
- 30 Jun 2020 - 30 Jun 2025
- Fact rows
- 6
What This Metric Tells You
- Shows reported interest expense over 30 Jun 2020 - 30 Jun 2025.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 6 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
- View Financial Facts Overview
- ALTERITY THERAPEUTICS LTD SEC filings
- Latest 10-Q/10-K Hub
- Open SEC Company Facts
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare This Metric Across Companies
Compare latest available Interest Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
ALTERITY THERAPEUTICS LTD appears at rank #11 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | WESTPAC BANKING CORP (webnf) | A$35,594,000,000 | Year - 30 Sep 2024 | Open WESTPAC BANKING CORP Interest Expense |
| 2 | Gelteq Ltd (gels) | A$1,917,720 | Year - 30 Jun 2025 | Open Gelteq Ltd Interest Expense |
| 3 | Australian Oilseeds Holdings Ltd (coot) | A$991,614 | Year - 30 Jun 2025 | Open Australian Oilseeds Holdings Ltd Interest Expense |
| 4 | Telix Pharmaceuticals Ltd (tlx) | A$82,000 | Year - 31 Dec 2024 | Open Telix Pharmaceuticals Ltd Interest Expense |
| 5 | Locafy Ltd (lcfy) | A$78,461 | Year - 30 Jun 2024 | Open Locafy Ltd Interest Expense |
| 6 | AVITA Medical, Inc. (rcel) | A$37,769 | Year - 30 Jun 2019 | Open AVITA Medical, Inc. Interest Expense |
Metric Details
- Metric
- Interest Expense (InterestExpense)
- Frequency coverage
- annual
- Taxonomy
- ifrs-full
- Units tracked
- AUD
- History range
- 30 Jun 2020 - 30 Jun 2025
- Facts on this page
- 6
- SEC metric endpoint
- Open SEC company concept
Metric identity
1 identity field
Metric coverage
3 source fields
Source evidence
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Interest Expense, Annual (AUD)
Interest Expense, YoY Annual Change (%)
ALTERITY THERAPEUTICS LTD Annual Interest Expense (AUD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | A$6,188 | -A$1,029 | -14% | 01 Jul 2024 | 30 Jun 2025 | 20-F | 29 Aug 2025 | 2025 | FY |
| 2024 | A$7,217 | +A$2,652 | +58% | 01 Jul 2023 | 30 Jun 2024 | 20-F | 29 Aug 2025 | 2025 | FY |
| 2023 | A$4,565 | +A$2,280 | +100% | 01 Jul 2022 | 30 Jun 2023 | 20-F | 29 Aug 2025 | 2025 | FY |
| 2022 | A$2,285 | +A$986 | +76% | 01 Jul 2021 | 30 Jun 2022 | 20-F | 26 Sep 2024 | 2024 | FY |
| 2021 | A$1,299 | -A$2,578 | -66% | 01 Jul 2020 | 30 Jun 2021 | 20-F | 31 Aug 2023 | 2023 | FY |
| 2020 | A$3,877 | 01 Jul 2019 | 30 Jun 2020 | 20-F | 31 Aug 2022 | 2022 | FY |
* marks a reported value that did not pass the local value check.